Literature DB >> 46026

Low-renin hypertension: nephrosclerosis?

J D Swales.   

Abstract

A substantial group of patients with essential hypertension have abnormally low renin levels which respond poorly to stimulation. Important differences in response to therapy and in prognosis have been described between these and other hypertensive patients. It is suggested that the vascular changes of nephrosclerosis, which may be seen in both hypertensive and normal subjects, result in a reduction of afferent arteriolar distensibility, with impairment of basal renin secretion and responsiveness. This hypothesis accords with both of the known clinical characteristics of low-renin hypertension and with the known effect of arterial changes upon the activity of other baroreceptors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46026     DOI: 10.1016/s0140-6736(75)91076-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man.

Authors:  P Weidmann; R de Chatel; A Schiffmann; E Bachmann; C Beretta-Piccoli; F C Reubi; W H Ziegler; W Vetter
Journal:  Klin Wochenschr       Date:  1977-08-01

2.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

Review 3.  Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly.

Authors:  P A Phillips; G P Hodsman; C I Johnston
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

4.  Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.

Authors:  B E Karlberg; B Kågedal; L Tegler; K Tolagen
Journal:  Br Med J       Date:  1976-01-31

5.  Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus.

Authors:  Patricia C Underwood; Bindu Chamarthi; Jonathan S Williams; Anand Vaidya; Rajesh Garg; Gail K Adler; Marissa P Grotzke; Gitana Staskus; Devendra Wadwekar; Paul N Hopkins; Claudio Ferri; Anthony McCall; Donald McClain; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.